For the year ending 2025-12-31, LSTA made $170K in revenue. -$16,586K in net income. Net profit margin of -9756.47%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Revenue | 170 | 1,000 | ||
| Research and development | 7,949 | 11,334 | ||
| General and administrative | 10,430 | 12,075 | ||
| Operating expenses | 18,379 | 23,409 | ||
| Operating loss | -18,209 | -22,409 | ||
| Investment income, net | 806 | 1,883 | ||
| Other expense, net | -145 | -257 | ||
| Total other income | 661 | 1,626 | ||
| Net loss before benefit from income taxes and noncontrolling interests | -17,548 | -20,783 | ||
| Benefit from income taxes | -962 | -798 | ||
| Net loss | -16,586 | -19,985 | ||
| Less - net income (loss) attributable to noncontrolling interests | 0 | - | ||
| Net loss attributable to lisata therapeutics, inc. common stockholders | -16,586 | -19,985 | ||
| Basic EPS | -1.91 | -2.4 | ||
| Diluted EPS | -1.91 | -2.4 | ||
| Basic Average Shares | 8,687,000 | 8,329,000 | ||
| Diluted Average Shares | 8,687,000 | 8,329,000 | ||
LISATA THERAPEUTICS, INC. (LSTA)
LISATA THERAPEUTICS, INC. (LSTA)